Loading patent…
AssigneeBuck Institute for Research on Aging
InventorsVarghese John, Dale E. Bredesen, Stelios Tzannis
Estimating the term…
In certain embodiments the methods of preventing or delaying the onset of a pre-Alzheimer's condition and/or cognitive dysfunction, and/or ameliorating one or more symptoms of a pre-Alzheimer's cognitive dysfunction, and/or preventing or delaying the progression of a pre-Alzheimer's condition or cognitive dysfunction to Alzheimer's disease, and/or of promoting the processing of amyloid precursor protein (APP) by the non-amyloidogenic pathway are provided. In certain embodiments the methods involve administering, or causing to be administered, to a subject in need thereof certain formulations comprising or more active agent(s) selected from the group consisting of tropisetron disulfiram, honokiol, nimetazepam, and/or derivatives or analogs thereof.
A prolonged release drug dosage formulation for peroral or oral transmucosal administration comprising a dissolvable drug formulation wherein said formulation comprises:
An drug dosage formulation comprising:
The method of 12, wherein said active agent(s) are administered in a pharmaceutical formulation wherein said active agent(s) are the principle active component(s).
The method of 12, wherein said active agent(s) are administered in a pharmaceutical formulation wherein said active agent(s) are the sole active component(s).
Dependencies are inferred from the claim text.